Clinical Trial Update: Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemoradiotherapy with or without sintilimab in limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Small Cell Lung Cancer Limited Stage | Phase 2 | Status: UNKNOWN